Home » Three-Way Collaboration Under Way on GMP Inspections
Three-Way Collaboration Under Way on GMP Inspections
February 17, 2009
The U.S. Food and Drug Administration, the European Medicines Agency (EMEA) and Australia’s Therapeutic Goods Administration have begun an 18-month pilot project to collaborate on good manufacturing practice (GMP) inspections.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor